Dorland Research Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-12-2024
- Paid Up Capital ₹ 0.50 M
as on 11-12-2024
- Company Age 33 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.70 M
as on 11-12-2024
- Revenue 2.09%
(FY 2022)
- Profit 354.61%
(FY 2022)
- Ebitda -33.16%
(FY 2022)
- Net Worth 73.17%
(FY 2022)
- Total Assets 3.39%
(FY 2022)
About Dorland Research Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹4.70 M.
Arunabha Banerjee, Prodip Chatterjee, and Ambar Roy serve as directors at the Company.
- CIN/LLPIN
U24232WB1991PTC051022
- Company No.
051022
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Mar 1991
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dorland Research Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arunabha Banerjee  | Managing Director | 05-Mar-1991 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prodip Chatterjee | Director | 18-Aug-2023 | Current |
| Ambar Roy | Director | 02-Aug-2021 | Current |
Financial Performance of Dorland Research Laboratories.
Dorland Research Laboratories Pvt Ltd, for the financial year ended 2022, experienced modest growth in revenue, with a 2.09% increase. The company also saw a substantial improvement in profitability, with a 354.61% increase in profit. The company's net worth Soared by an impressive increase of 73.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dorland Research Laboratories?
In 2021, Dorland Research Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
United Bank Of India Creation Date: 07 Apr 2006 | ₹3.50 M | Open |
Allahabad Bank Creation Date: 23 Feb 2000 | ₹1.20 M | Open |
How Many Employees Work at Dorland Research Laboratories?
Dorland Research Laboratories has a workforce of 6 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dorland Research Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dorland Research Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
